Back to PE Pentwater Capital Management LP
CEREShowing 1 of 4 quarters
Position history for PEPentwater Capital Management LP's holdings in CEREVEL THERAPEUTICS HLDNG I
As of its Q2 2024 13F, Pentwater Capital Management held 1,878,719 shares of CERE (Cerevel Therapeutics Hldng), worth $76.8M. Pentwater Capital Management's 13F filings listed CERE from Q4 2023 to Q2 2024, 3 quarterly filings. CERE was 1.0% of Pentwater Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CERE: FMR LLC